Close menu

Our news are not all translated. For an exhaustive

list of our news, please consult the French version.

oct. 6th, 2022

ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes

Using M1Pram in a post-hoc analysis.

oct. 6th, 2022

ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes

Using M1Pram in a post-hoc analysis.

oct. 6th, 2022

ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes

Using M1Pram in a post-hoc analysis.